COHANCE LIFESCIENCES
Back to Balance Sheet
|
COHANCE LIFESCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹5,727 Cr | ₹5,480 Cr | ₹2,254 Cr | ₹2,110 Cr | ₹1,967 Cr |
What is the latest Total Liabilities ratio of COHANCE LIFESCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹5,727 Cr |
| Mar2025 | ₹5,480 Cr |
| Mar2024 | ₹2,254 Cr |
| Mar2023 | ₹2,110 Cr |
| Mar2022 | ₹1,967 Cr |
How is Total Liabilities of COHANCE LIFESCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,727 Cr | 4.50 | |
| Mar2025 | ₹5,480 Cr | 143.13 | |
| Mar2024 | ₹2,254 Cr | 6.83 | |
| Mar2023 | ₹2,110 Cr | 7.28 | |
| Mar2022 | ₹1,967 Cr | - | |
Compare Total Liabilities of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹16,995.1 Cr | -2.2% | -2.6% | -49.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | -2.2% |
-2.6% |
-49.1% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses